Author:
Ibrahim MohammedA,Shehta Mohammed
Reference12 articles.
1. Fluvoxamine alleviates ER stress via induction of sigma-1 receptor;Omi;Cell Death Dis,2014
2. Hashimoto K Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication. J Pharmacol Sci 2015; 127:6–9.
3. Safety and efficacy of fluvoxamine in COVID-19 ICU patients: An open label, prospective cohort trial with matched controls;Calusic;Br J Clin Pharmacol,2021
4. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial;Lenze;JAMA,2020
5. Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis;Rosen;Sci Transl Med,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献